查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球氧气浓缩机市场（按类型、技术、流量、应用、最终用户和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1811729

全球氧气浓缩机市场（按类型、技术、流量、应用、最终用户和地区划分）- 预测至 2030 年

Oxygen Concentrators Market by Type, Technology, Flowrate, Application, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 246 Pages | 订单完成后即时交付

价格

预计氧气浓缩机市场将从 2025 年的 12.7 亿美元成长到 2030 年的 17.1 亿美元，预测期内的复合年增长率为 6.1%。

调查范围
调查年份 2024-2030
基准年 2024
预测期 2025-2030
对价单位 金额（十亿美元）
部分 按类型、技术、流量、应用、最终用户和地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲、海湾合作委员会国家

技术进步对于推动氧气浓缩机市场的成长至关重要。最新的氧气浓缩机更加紧凑、轻巧、节能且用户友好。脉衝定量技术等创新技术，尤其是在可携式型号中，仅在吸气时输送氧气，以节省氧气并延长电池寿命。较新的设备运作安静，配备数位显示器、警报器、远端监控连接，并支援脉衝流和连续流模式。

氧气浓缩器市场-IMG1

配备长效电池的携带式製氧机深受活跃用户和旅客的欢迎，有些甚至核准了美国联邦航空管理局 (FAA) 的航空许可。物联网整合可与医疗保健提供者即时共用数据，从而提高患者的依从性。人工智慧演算法可根据呼吸模式优化供氧。这些技术创新提高了便利性、病患生活品质并拓宽了适用范围，随着采用率的提高，市场也随之成长。

按类型，市场分为携带式氧气浓缩机和固定式氧气浓缩机。到2024年，携带式氧气浓缩机器将占全球氧气浓缩机市场的最大份额。全球老年人口的成长是推动携带式氧气浓缩机（POC）需求的主要因素。老年人易患慢性呼吸系统疾病，如慢性阻塞性肺病、肺纤维化和与心臟衰竭相关的缺氧。随着年龄的增长，行动变得越来越困难，POC 提供了一种实用的解决方案，使老年患者能够接受氧气疗法不受固定设备的限制。无论是在家、户外或旅行时，携带氧气设备的能力都大大提高了患者的独立性和生活品质。随着老龄化人口的不断增长，特别是在北美、欧洲和亚洲部分地区等发达地区，对 POC 等紧凑、可靠且易于使用的氧气设备的需求正在稳步增长，从而增强了它们的市场主导地位。

按最终用户划分，制氧机市场分为居家照护机构、医院和诊所、门诊手术中心和医生办公室。预计到 2024 年，居家医疗机构将占据制氧机市场的最大份额。全球老年人口的成长是氧气浓缩机市场居家照护领域需求的主要驱动力。老年人易患慢性呼吸系统疾病，如慢性阻塞性肺病(COPD)、肺气肿及与老龄化相关的肺功能下降。这些疾病通常需要长期氧气疗法，而家庭氧气疗法因其便利性和低成本而日益流行。此外，老年患者通常行动不便，也难以频繁到医院就诊。家用氧气浓缩机提供了一种安全且易于使用的解决方案，使他们能够保持独立，同时保持持续的呼吸支持。在人口老化快速发展的国家，如日本、德国、义大利和美国，居家医疗机构对氧气浓缩机的采用尤其强烈。

预计北美将在预测期内占据 OC 市场的最大份额。北美，特别是美国和加拿大，拥有高度发展的医疗保健系统和最新的诊断和治疗技术。该地区的医院、诊所和门诊中心可以广泛使用氧气输送设备，包括浓缩器。此外，结构化的医疗保健政策、综合保险网络和简化的采购管道确保了这些设备的顺利供应和分销。患者可受益于更快的诊断和及时开始氧气疗法。家庭护理支持系统也在进步，透过持续的氧气支持实现从医院到家庭的安全过渡。这些有利条件改善了氧气浓缩机的取得和使用，特别是对于慢性病患者，巩固了北美在全球氧气浓缩机市场的主导地位。

本报告研究了全球氧气浓缩机市场，并根据类型、技术、流量、应用、最终用户、区域趋势和公司概况对市场进行了全面的分析。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/中断
  • 定价分析
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 产业趋势
  • 专利分析
  • 贸易分析
  • 2025-2026年主要会议和活动
  • 案例研究分析
  • 监管分析
  • 监管机构、政府机构和其他组织
  • 波特五力分析
  • 主要相关人员和采购标准
  • 未满足的需求/最终用户期望
  • 2025年美国关税对氧气浓缩机市场的影响
  • 人工智慧对氧气浓缩机市场的影响
  • 邻近市场分析

第六章氧气浓缩机市场（按类型）

  • 介绍
  • 携带式氧气浓缩机
  • 固定式氧气浓缩机

第七章氧气浓缩机市场（依技术）

  • 介绍
  • 连续型
  • 脉衝流型

第八章氧气浓缩机市场（按流量）

  • 介绍
  • 0-5公升/分钟
  • 5-10公升/分钟
  • 10公升/分钟以上

第九章氧气浓缩机市场（依应用）

  • 介绍
  • COPD
  • 气喘
  • 呼吸困难
  • 其他的

第 10 章。氧气浓缩机市场（按最终用户）

  • 介绍
  • 居家照护
  • 医院和诊所
  • 门诊手术中心及诊所

第 11 章氧气浓缩机市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
  • 海湾合作委员会国家
    • 海湾合作委员会国家宏观经济展望

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收益分析
  • 市场占有率分析
  • 公司估值矩阵：2024 年关键参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十三章：公司简介

  • 主要参与企业
    • KONINKLIJKE PHILIPS NV
    • INOGEN, INC.
    • JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.
    • CAIRE INC.
    • DRIVE DEVILBISS HEALTHCARE
    • TEIJIN LIMITED
    • DAIKIN INDUSTRIES, LTD.
    • ESAB CORPORATION（GCE GROUP）
    • REACT HEALTH
    • PRECISION MEDICAL, INC.
    • NIDEK MEDICAL PRODUCTS, INC.
    • O2 CONCEPTS, LLC
    • BPL MEDICAL TECHNOLOGIES
    • BESCO
    • OXUS
  • 其他公司
    • FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD
    • LONGFIAN SCITECH CO., LTD.
    • SHENYANG CANTA MEDICAL TECH. CO., LTD.
    • BELLUSCURA
    • HOYO SCITECH CO., LTD.
    • HACENOR SOLUTIONS
    • XNUO INTERNATIONAL GROUP（USA）HOLDINGS
    • OXYMED
    • KALSTEIN
    • ESS PEE ENTERPRISES

第十四章 附录

Product Code: MD 9480

The oxygen concentrators market is projected to reach USD 1.71 billion by 2030 from USD 1.27 billion in 2025, at a CAGR of 6.1% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsType, Technology, Flowrate, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries

Technological advancements are crucial in driving growth in the oxygen concentrators market. Modern units are more compact, lightweight, energy-efficient, and user-friendly. Innovations like pulse dose technology deliver oxygen only during inhalation to conserve it and extend battery life, especially in portable models. New devices feature silent operation, digital displays, alarms, connectivity for remote monitoring, and support both pulse and continuous flow modes.

Oxygen Concentrators Market - IMG1

Portable concentrators with long-lasting batteries are popular among active users and travelers, some FAA-approved for flights. IoT integration enables real-time data sharing with healthcare providers, enhancing patient compliance. AI algorithms optimize oxygen delivery based on respiratory patterns. These innovations improve convenience, patient quality of life, and broaden application scope, fueling market growth as adoption increases.

Based on type, the market is divided into portable and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrator market. The increasing global geriatric population is a key factor driving demand for portable oxygen concentrators (POCs). Older adults are more vulnerable to chronic respiratory conditions such as COPD, pulmonary fibrosis, and hypoxia related to heart failure. Mobility challenges in old age make POCs a practical solution, allowing elderly patients to receive oxygen therapy without being restricted to a stationary device. Being able to carry oxygen support while moving around at home, outdoors, or during travel greatly improves their independence and quality of life. As the aging population continues to grow-especially in developed areas like North America, Europe, and parts of Asia-the demand for compact, dependable, and easy-to-use oxygen devices like POCs steadily increases, strengthening their market dominance.

Based on end users, the OC market has been categorized into home care settings, hospitals and clinics, and ambulatory surgical centers & physician offices. In 2024, home care settings held the largest share in the OC market. The increasing global elderly population is a key factor driving demand in the home care segment of the oxygen concentrators market. Older adults are more vulnerable to chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and age-related decline in lung function. These conditions often require long-term oxygen therapy, which is increasingly managed at home due to its convenience and lower cost. Additionally, elderly patients often face mobility issues, making frequent hospital visits difficult. Home-based oxygen concentrators provide a safe and accessible solution, allowing independence while maintaining continuous respiratory support. Countries like Japan, Germany, Italy, and the US-with rapidly aging populations-are seeing a particularly high adoption of oxygen concentrators in home care settings.

North America is expected to hold the largest share of the OC market during the forecast period. North America, especially the US and Canada, has highly developed healthcare systems equipped with modern diagnostic and therapeutic technologies. The region's hospitals, clinics, and outpatient centers have widespread access to oxygen delivery equipment, including concentrators. Additionally, structured healthcare policies, integrated insurance networks, and streamlined procurement channels ensure the smooth availability and distribution of these devices. Patients benefit from faster diagnoses and prompt initiation of oxygen therapy. Home care support systems are also advanced, allowing a safe transition from hospital to home with continuous oxygen support. These favorable conditions improve the accessibility and use of oxygen concentrators, especially for chronic patients, and reinforce North America's leadership position in the global oxygen concentrators market.

A breakdown of the primary participants (supply-side) for the oxygen concentrators market referred to in this report is provided below:

  • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
  • By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
  • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Major players in the oxygen concentrators market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), Caire, Inc. (US), and Drive DeVilbiss Healthcare (US).

Research Coverage

The report assesses the oxygen concentrators market and estimates its size and future growth potential across various segments, including type, technology, flow rate, application, end user, and region. It also provides a competitive analysis of the leading companies in the market, along with their profiles, product offerings, recent developments, and key strategies.

Reasons to Buy the Report

The report will help market leaders and new entrants by providing data on the closest estimates of revenue for the overall oxygen concentrators market and its subsegments. It will aid stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp market trends and offers data on key drivers, obstacles, challenges, and opportunities within the market.

This report provides insights into the following points:

  • Analysis of key drivers (rising prevalence of respiratory diseases, growing geriatric population, increasing demand for home healthcare, government initiatives and reimbursement support, technological advancements), restraints (high cost of advanced oxygen concentrators, product recalls or malfunctions), opportunities (integration of digital health features, development of solar-powered or battery-efficient models) and challenges (lack of awareness and diagnosis, competition from low-cost alternatives)
  • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global OC market
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, technology, flowrate, application, end user, and region
  • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global OC market
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global OC market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS COVERED
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY USED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 OXYGEN CONCENTRATORS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY AND COUNTRY
  • 4.3 OXYGEN CONCENTRATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 OXYGEN CONCENTRATORS MARKET, REGIONAL MIX
  • 4.5 OXYGEN CONCENTRATORS MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of chronic respiratory diseases
      • 5.2.1.2 Preference for home-based oxygen therapy
      • 5.2.1.3 Technological advancements in portable oxygen concentrators
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High initial cost and limited reimbursement in some markets
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expansion in emerging markets
      • 5.2.3.2 Integration with remote monitoring and telehealth
      • 5.2.3.3 Institutional demand and tender-based opportunities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Operational limitations in remote and power-constrained areas
      • 5.2.4.2 Quality variability and regulatory compliance challenges
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE
    • 5.4.2 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Pressure swing adsorption (PSA) technology
      • 5.9.1.2 Pulse-dose vs. continuous flow delivery
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Remote patient monitoring (RPM) integration
      • 5.9.2.2 Battery and power management systems
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 PSA oxygen plants
      • 5.9.3.2 Oxygen cylinders as backup systems
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 RISING DEMAND FOR HOME-BASED OXYGEN THERAPY
    • 5.10.2 INTEGRATION WITH TELEHEALTH AND REMOTE MONITORING
    • 5.10.3 SHIFT TOWARD PORTABLE AND WEARABLE TECHNOLOGIES
    • 5.10.4 CONSOLIDATION AND COMPETITIVE LANDSCAPE EVOLUTION
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 IMPORT DATA (HS CODE 901920)
    • 5.12.2 EXPORT DATA (HS CODE 901920)
  • 5.13 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 DEPLOYMENT OF PORTABLE OXYGEN CONCENTRATORS IN RURAL INDIA
    • 5.14.2 INOGEN'S DIRECT-TO-CONSUMER EXPANSION IN US
    • 5.14.3 BELLUSCURA'S STRATEGIC PARTNERSHIP WITH CHINESE OEM
  • 5.15 REGULATORY ANALYSIS
  • 5.16 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.16.1 REGULATORY LANDSCAPE
      • 5.16.1.1 North America
        • 5.16.1.1.1 US
        • 5.16.1.1.2 Canada
      • 5.16.1.2 Europe
        • 5.16.1.2.1 Germany
        • 5.16.1.2.2 France
        • 5.16.1.2.3 UK
      • 5.16.1.3 Asia Pacific
        • 5.16.1.3.1 China
        • 5.16.1.3.2 Japan
        • 5.16.1.3.3 India
      • 5.16.1.4 Latin America
        • 5.16.1.4.1 Brazil
        • 5.16.1.4.2 Mexico
      • 5.16.1.5 Middle East & Africa
        • 5.16.1.5.1 South Africa
        • 5.16.1.5.2 GCC Countries
  • 5.17 PORTER'S FIVE FORCES ANALYSIS
    • 5.17.1 THREAT OF NEW ENTRANTS
    • 5.17.2 THREAT OF SUBSTITUTES
    • 5.17.3 BARGAINING POWER OF SUPPLIERS
    • 5.17.4 BARGAINING POWER OF BUYERS
    • 5.17.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.18 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.18.2 BUYING CRITERIA
  • 5.19 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.20 IMPACT OF 2025 US TARIFF ON OXYGEN CONCENTRATORS MARKET
    • 5.20.1 KEY TARIFF RATES
    • 5.20.2 PRICE IMPACT ANALYSIS
    • 5.20.3 KEY IMPACT ON COUNTRY/REGION
      • 5.20.3.1 US
      • 5.20.3.2 Europe
      • 5.20.3.3 Asia Pacific
    • 5.20.4 IMPACT ON END-USER INDUSTRIES
  • 5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON OXYGEN CONCENTRATORS MARKET
  • 5.22 ADJACENT MARKET ANALYSIS

6 OXYGEN CONCENTRATORS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 PORTABLE OXYGEN CONCENTRATORS
  • 6.3 STATIONARY OXYGEN CONCENTRATORS

7 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 CONTINUOUS FLOW
  • 7.3 PULSE FLOW

8 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE

  • 8.1 INTRODUCTION
  • 8.2 0-5 L/MIN FLOWRATE
  • 8.3 5-10 L/MIN FLOWRATE
  • 8.4 ABOVE 10 L/MIN FLOWRATE

9 OXYGEN CONCENTRATORS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 COPD
  • 9.3 ASTHMA
  • 9.4 RESPIRATORY DISTRESS
  • 9.5 OTHER APPLICATIONS

10 OXYGEN CONCENTRATORS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOME CARE SETTINGS
  • 10.3 HOSPITALS & CLINICS
  • 10.4 AMBULATORY SURGICAL CENTERS & PHYSICIANS' OFFICES

11 OXYGEN CONCENTRATORS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Medicare coverage, COPD prevalence, and connected POCs to catalyze sustained market expansion through 2030
    • 11.2.3 CANADA
      • 11.2.3.1 Provincial funding, COPD burden, and connected POCs to accelerate home oxygen concentrator adoption trajectory
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Strong payer coverage and clinical guidelines to drive predictable replacement cycles in Germany's market
    • 11.3.3 FRANCE
      • 11.3.3.1 Hospital-to-home shift and connected devices sustain resilient replacement cycles in France's oxygen concentrators market
    • 11.3.4 UK
      • 11.3.4.1 Aging population and funded home oxygen programs to underpin steady expansion
    • 11.3.5 ITALY
      • 11.3.5.1 Regional tenders, SSN homecare funding, and COPD burden to support steady growth in Italy's market
    • 11.3.6 SPAIN
      • 11.3.6.1 Driving home-based healthcare with portable oxygen concentrator growth
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Stable funding and service-led home care models to support steady growth
    • 11.4.3 CHINA
      • 11.4.3.1 Policy momentum and robust manufacturing ecosystem to drive resilient replacement cycles
    • 11.4.4 INDIA
      • 11.4.4.1 Building resilient healthcare infrastructure with rising oxygen concentrator demand
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Hospital-to-home shift and connected POCs to propel South Korea's portable and stationary oxygen concentrator demand growth
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Policy support, service networks, and digital monitoring to drive steady expansion of Australia's market through 2030
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Public procurement, ANVISA registration, and service networks to drive predictable replacement cycles in Brazil's oxygen therapy landscape
    • 11.5.3 MEXICO
      • 11.5.3.1 Strengthening respiratory care access through expanding oxygen concentrator adoption
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Regional footprint
      • 12.5.5.3 Type footprint
      • 12.5.5.4 Application footprint
      • 12.5.5.5 End User footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of startups/SMEs
  • 12.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 KONINKLIJKE PHILIPS N.V.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 MnM view
        • 13.1.1.3.1 Right to win
        • 13.1.1.3.2 Strategic choices
        • 13.1.1.3.3 Weaknesses and competitive threats
    • 13.1.2 INOGEN, INC.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches & approvals
        • 13.1.2.3.2 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 CAIRE INC.
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches & approvals
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 DRIVE DEVILBISS HEALTHCARE
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches & approvals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 TEIJIN LIMITED
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
    • 13.1.7 DAIKIN INDUSTRIES, LTD.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
    • 13.1.8 ESAB CORPORATION (GCE GROUP)
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
    • 13.1.9 REACT HEALTH
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Deals
    • 13.1.10 PRECISION MEDICAL, INC.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 NIDEK MEDICAL PRODUCTS, INC.
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
    • 13.1.12 O2 CONCEPTS, LLC
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Product launches & approvals
        • 13.1.12.3.2 Deals
    • 13.1.13 BPL MEDICAL TECHNOLOGIES
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
    • 13.1.14 BESCO
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
    • 13.1.15 OXUS
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
  • 13.2 OTHER COMPANIES
    • 13.2.1 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD
    • 13.2.2 LONGFIAN SCITECH CO., LTD.
    • 13.2.3 SHENYANG CANTA MEDICAL TECH. CO., LTD.
    • 13.2.4 BELLUSCURA
    • 13.2.5 HOYO SCITECH CO., LTD.
    • 13.2.6 HACENOR SOLUTIONS
    • 13.2.7 XNUO INTERNATIONAL GROUP (USA) HOLDINGS
    • 13.2.8 OXYMED
    • 13.2.9 KALSTEIN
    • 13.2.10 ESS PEE ENTERPRISES

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 USD STANDARD CURRENCY CONVERSION RATES, 2020-2024
  • TABLE 2 RISK ASSESSMENT: OXYGEN CONCENTRATORS
  • TABLE 3 OXYGEN CONCENTRATORS MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS
  • TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2022-2024 (USD)
  • TABLE 6 OXYGEN CONCENTRATORS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 IMPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 8 EXPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 9 OXYGEN CONCENTRATORS MARKET: KEY CONFERENCES & EVENTS, 2025-2026
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 OXYGEN CONCENTRATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS
  • TABLE 17 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024
  • TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OXYGEN CONCENTRATORS
  • TABLE 20 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 21 EXAMPLES OF PORTABLE OXYGEN CONCENTRATORS (POC)
  • TABLE 22 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 23 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2023-2030 (UNITS)
  • TABLE 24 EXAMPLES OF STATIONARY OXYGEN CONCENTRATORS (POC)
  • TABLE 25 STATIONARY OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 26 STATIONARY OXYGEN CONCENTRATORS MARKET, BY REGION, 2023-2030 (UNITS)
  • TABLE 27 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 28 CONTINUOUS-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 PULSE-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 31 0-5 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 5-10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 ABOVE 10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 35 OXYGEN CONCENTRATORS MARKET FOR COPD, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 OXYGEN CONCENTRATORS MARKET FOR ASTHMA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 OXYGEN CONCENTRATORS MARKET FOR RESPIRATORY DISTRESS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 OXYGEN CONCENTRATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 40 OXYGEN CONCENTRATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 OXYGEN CONCENTRATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 OXYGEN CONCENTRATORS MARKET FOR AMBULATORY SURGICAL CENTERS & PHYSICIANS' OFFICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 OXYGEN CONCENTRATORS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 48 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 50 US: MACROECONOMIC INDICATORS
  • TABLE 51 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 52 US: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 53 US: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 54 US: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 55 US: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 56 CANADA: MACROECONOMIC INDICATORS
  • TABLE 57 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 58 CANADA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 59 CANADA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 60 CANADA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 61 CANADA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 62 EUROPE: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 66 EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 67 EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 68 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 69 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 71 GERMANY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 72 GERMANY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 73 GERMANY: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 75 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 77 FRANCE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 78 FRANCE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 79 FRANCE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 80 UK: MACROECONOMIC INDICATORS
  • TABLE 81 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 UK: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 83 UK: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 84 UK: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 85 UK: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 86 ITALY: MACROECONOMIC INDICATORS
  • TABLE 87 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 ITALY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 89 ITALY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 90 ITALY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 91 ITALY: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 92 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 93 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 95 SPAIN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 96 SPAIN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 97 SPAIN: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 98 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 100 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 101 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 102 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 109 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 110 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 112 JAPAN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 113 JAPAN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 114 JAPAN: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 115 CHINA: MACROECONOMIC INDICATORS
  • TABLE 116 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 CHINA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 118 CHINA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 119 CHINA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 120 CHINA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 121 INDIA: MACROECONOMIC INDICATORS
  • TABLE 122 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 INDIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 124 INDIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 125 INDIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 126 INDIA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 128 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 130 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 131 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 132 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 134 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 136 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 137 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 138 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 144 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 147 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 148 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 150 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 151 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 153 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 154 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 155 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 156 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 157 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 159 MEXICO: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 160 MEXICO: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 161 MEXICO: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 162 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 164 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 165 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023-2030 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 177 KEY DEVELOPMENTS IN OXYGEN CONCENTRATORS MARKET, JANUARY 2021-JULY 2025
  • TABLE 178 OXYGEN CONCENTRATORS MARKET: DEGREE OF COMPETITION
  • TABLE 179 OXYGEN CONCENTRATORS MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 180 OXYGEN CONCENTRATORS MARKET: TYPE FOOTPRINT, 2024
  • TABLE 181 OXYGEN CONCENTRATORS MARKET: APPLICATION FOOTPRINT, 2024
  • TABLE 182 OXYGEN CONCENTRATORS MARKET: END USER FOOTPRINT, 2024
  • TABLE 183 OXYGEN CONCENTRATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
  • TABLE 184 OXYGEN CONCENTRATORS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
  • TABLE 185 OXYGEN CONCENTRATORS MARKET: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 186 OXYGEN CONCENTRATORS MARKET: DEALS, JANUARY 2021-JULY 2025
  • TABLE 187 OXYGEN CONCENTRATORS MARKET: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 188 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 189 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 190 INOGEN, INC.: COMPANY OVERVIEW
  • TABLE 191 INOGEN, INC.: PRODUCTS OFFERED
  • TABLE 192 INOGEN, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JULY 2025
  • TABLE 193 INOGEN INC.: DEALS
  • TABLE 194 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: COMPANY OVERVIEW
  • TABLE 195 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: PRODUCTS OFFERED
  • TABLE 196 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD..: DEALS
  • TABLE 197 CAIRE INC.: COMPANY OVERVIEW
  • TABLE 198 CAIRE INC.: PRODUCTS OFFERED
  • TABLE 199 CAIRE INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 200 CAIRE INC.: DEALS
  • TABLE 201 CAIRE INC.: EXPANSIONS
  • TABLE 202 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 203 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 204 DRIVE DEVILBISS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
  • TABLE 205 TEIJIN LIMITED: COMPANY OVERVIEW
  • TABLE 206 TEIJIN LIMITED: PRODUCTS OFFERED
  • TABLE 207 DAIKIN INDUSTRIES, LTD.: COMPANY OVERVIEW
  • TABLE 208 DAIKIN INDUSTRIES, LTD.: PRODUCTS OFFERED
  • TABLE 209 ESAB CORPORATION (GCE GROUP): COMPANY OVERVIEW
  • TABLE 210 ESAB CORPORATION (GCE GROUP): PRODUCTS OFFERED
  • TABLE 211 REACT HEALTH: COMPANY OVERVIEW
  • TABLE 212 REACT HEALTH: PRODUCTS OFFERED
  • TABLE 213 REACT HEALTH.: DEALS, JANUARY 2021-JULY 2025
  • TABLE 214 PRECISION MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 215 PRECISION MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 216 NIDEK MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 217 NIDEK MEDICAL PRODUCTS, INC.: PRODUCTS OFFERED
  • TABLE 218 O2 CONCEPTS, LLC: COMPANY OVERVIEW
  • TABLE 219 O2 CONCEPTS, LLC: PRODUCTS OFFERED
  • TABLE 220 O2 CONCEPTS, LLC: PRODUCT LAUNCHES & APPROVALS
  • TABLE 221 O2 CONCEPTS, LLC: DEALS
  • TABLE 222 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 223 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 224 BESCO: COMPANY OVERVIEW
  • TABLE 225 BESCO: PRODUCTS OFFERED
  • TABLE 226 OXUS: COMPANY OVERVIEW
  • TABLE 227 OXUS: PRODUCTS OFFERED
  • TABLE 228 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD: COMPANY OVERVIEW
  • TABLE 229 LONGFIAN SCITECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 230 SHENYANG CANTA MEDICAL TECH. CO., LTD.: COMPANY OVERVIEW
  • TABLE 231 BELLUSCURA: COMPANY OVERVIEW
  • TABLE 232 HOYO SCITECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 233 HACENOR SOLUTIONS: COMPANY OVERVIEW
  • TABLE 234 XNUO INTERNATIONAL GROUP (USA) HOLDINGS: COMPANY OVERVIEW
  • TABLE 235 OXYMED: COMPANY OVERVIEW
  • TABLE 236 KALSTEIN: COMPANY OVERVIEW
  • TABLE 237 ESS PEE ENTERPRISES: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 OXYGEN CONCENTRATORS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 KEY DATA FROM SECONDARY RESEARCH
  • FIGURE 4 PRIMARY SOURCES
  • FIGURE 5 KEY DATA FROM PRIMARY SOURCES
  • FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION
  • FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 11 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
  • FIGURE 12 SUPPLY-SIDE MARKET SIZE ESTIMATION: OXYGEN CONCENTRATORS, 2024
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2025-2030
  • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 15 TOP-DOWN APPROACH
  • FIGURE 16 DATA TRIANGULATION METHODOLOGY
  • FIGURE 17 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 OXYGEN CONCENTRATORS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 GEOGRAPHICAL SNAPSHOT OF OXYGEN CONCENTRATORS MARKET
  • FIGURE 23 RISING INVESTMENTS IN HEALTHCARE, DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES, AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH
  • FIGURE 24 JAPAN AND PORTABLE OXYGEN CONCENTRATORS ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN ASIA PACIFIC IN 2024
  • FIGURE 25 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 26 NORTH AMERICA TO DOMINATE OXYGEN CONCENTRATORS MARKET
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 28 OXYGEN CONCENTRATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2022-2024 (USD)
  • FIGURE 31 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES
  • FIGURE 32 OXYGEN CONCENTRATORS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 OXYGEN CONCENTRATORS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 34 OXYGEN CONCENTRATORS MARKET: INVESTMENT & FUNDING SCENARIO, 2019-2023
  • FIGURE 35 OXYGEN CONCENTRATORS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 36 OXYGEN CONCENTRATORS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 37 OXYGEN CONCENTRATORS MARKET: PATENT ANALYSIS, JANUARY 2015-JULY 2025
  • FIGURE 38 OXYGEN CONCENTRATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS
  • FIGURE 40 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS
  • FIGURE 41 OXYGEN CONCENTRATORS MARKET: IMPACT OF AI/GEN AI
  • FIGURE 42 OXYGEN CONCENTRATORS MARKET: ADJACENT MARKETS
  • FIGURE 43 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET SNAPSHOT
  • FIGURE 44 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET SNAPSHOT
  • FIGURE 45 REVENUE ANALYSIS OF TOP PLAYERS IN OXYGEN CONCENTRATORS MARKET, 2020-2024 (USD MILLION)
  • FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 47 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 48 OXYGEN CONCENTRATORS MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 49 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 50 EV/EBITDA OF KEY VENDORS, 2025
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 52 OXYGEN CONCENTRATORS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 54 INOGEN, INC.: COMPANY SNAPSHOT
  • FIGURE 55 TEIJIN LIMITED: COMPANY SNAPSHOT
  • FIGURE 56 DAIKIN INDUSTRIES, LTD.: COMPANY SNAPSHOT
  • FIGURE 57 ESAB CORPORATION (GCE GROUP): COMPANY SNAPSHOT